Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
22 auth.
T. Asselah,
K. Kowdley,
Neddie Zadeikis,
Stanley Wang,
T. Hassanein,
Y. Horsmans,
M. Colombo,
F. Calinas,
H. Aguilar,
V. de Lédinghen,
...
P. Mantry,
C. Hézode,
R. Marinho,
K. Agarwal,
F. Nevens,
M. Elkhashab,
J. Kort,
Ran Liu,
T. Ng,
Preethi Krishnan,
Chih‐Wei Lin,
F. Mensa
|
|
8 |
2017 |
Social Media Posts